Skip to main content

Some NLM-NCBI services and products are experiencing heavy traffic, which may affect performance and availability. We apologize for the inconvenience and appreciate your patience. For assistance, please contact our Help Desk at info@ncbi.nlm.nih.gov.

The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Dec 15;98(12):2786–2793. doi: 10.1172/JCI119105

Effects of tacrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells.

J B Redmon 1, L K Olson 1, M B Armstrong 1, M J Greene 1, R P Robertson 1
PMCID: PMC507744  PMID: 8981925

Abstract

FK506 (tacrolimus) is an immunosuppressive drug which interrupts Ca2+-calmodulin-calcineurin signaling pathways in T lymphocytes, thereby blocking antigen activation of T cell early activation genes. Regulation of insulin gene expression in the beta cell may also involve Ca2+-signaling pathways and FK506 has been associated with insulin-requiring diabetes mellitus during clinical use. The purpose of this study was to characterize the effects of FK506 on human insulin gene transcription, insulin mRNA levels, and insulin secretion using as a model the HIT-T15 beta cell line. FK506 had no acute effect on insulin secretion in the HIT cell, but caused a reversible time- and dose-dependent (10(-9)-10(-6) M) decrease in HIT cell insulin secretion. Decreased insulin secretion in the presence of FK506 was also accompanied by a dose-dependent decrease in HIT cell insulin content, insulin mRNA levels, and expression of a human insulin promoter-chloramphenicol acetyl transferase (CAT) reporter gene. FK506 decreased HIT cell expression of the human insulin promoter-CAT reporter gene by 40% in the presence of both low (0.4 mM) at high (20 mM) glucose concentrations. Western blot analysis of HIT cell proteins gave evidence for the presence of calcineurin in the HIT cell. These findings suggest that FK506 may have direct effects to reversibly inhibit insulin gene transcription, leading to a decline in insulin mRNA levels, insulin synthesis, and ultimately insulin secretion.

Full Text

The Full Text of this article is available as a PDF (223.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armitage J. M., Kormos R. L., Morita S., Fung J., Marrone G. C., Hardesty R. L., Griffith B. P., Starzl T. E. Clinical trial of FK 506 immunosuppression in adult cardiac transplantation. Ann Thorac Surg. 1992 Aug;54(2):205–211. doi: 10.1016/0003-4975(92)91371-f. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bosser R., Aligué R., Guerini D., Agell N., Carafoli E., Bachs O. Calmodulin can modulate protein phosphorylation in rat liver cells nuclei. J Biol Chem. 1993 Jul 25;268(21):15477–15483. [PubMed] [Google Scholar]
  3. Brunstedt J., Chan S. J. Direct effect of glucose on the preproinsulin mRNA level in isolated pancreatic islets. Biochem Biophys Res Commun. 1982 Jun 30;106(4):1383–1389. doi: 10.1016/0006-291x(82)91267-0. [DOI] [PubMed] [Google Scholar]
  4. Carroll P. B., Boschero A. C., Li M. Y., Tzakis A. G., Starzl T. E., Atwater I. Effect of the immunosuppressant FK506 on glucose-induced insulin secretion from adult rat islets of Langerhans. Transplantation. 1991 Jan;51(1):275–278. doi: 10.1097/00007890-199101000-00048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Docherty K., Clark A. R., Scott V., Knight S. W. Metabolic control of insulin gene expression and biosynthesis. Proc Nutr Soc. 1991 Dec;50(3):553–558. doi: 10.1079/pns19910068. [DOI] [PubMed] [Google Scholar]
  6. Efrat S., Surana M., Fleischer N. Glucose induces insulin gene transcription in a murine pancreatic beta-cell line. J Biol Chem. 1991 Jun 15;266(17):11141–11143. [PubMed] [Google Scholar]
  7. Enslen H., Soderling T. R. Roles of calmodulin-dependent protein kinases and phosphatase in calcium-dependent transcription of immediate early genes. J Biol Chem. 1994 Aug 19;269(33):20872–20877. [PubMed] [Google Scholar]
  8. Fehmann H. C., Habener J. F. Galanin inhibits proinsulin gene expression stimulated by the insulinotropic hormone glucagon-like peptide-I(7-37) in mouse insulinoma beta TC-1 cells. Endocrinology. 1992 May;130(5):2890–2896. doi: 10.1210/endo.130.5.1374016. [DOI] [PubMed] [Google Scholar]
  9. Fung J. J., Alessiani M., Abu-Elmagd K., Todo S., Shapiro R., Tzakis A., Van Thiel D., Armitage J., Jain A., McCauley J. Adverse effects associated with the use of FK 506. Transplant Proc. 1991 Dec;23(6):3105–3108. [PMC free article] [PubMed] [Google Scholar]
  10. Gagliardino J. J., Krinks M. H., Gagliardino E. E. Identification of the calmodulin-regulated protein phosphatase, calcineurin, in rat pancreatic islets. Biochim Biophys Acta. 1991 Feb 19;1091(3):370–373. doi: 10.1016/0167-4889(91)90202-9. [DOI] [PubMed] [Google Scholar]
  11. German M. S., Moss L. G., Rutter W. J. Regulation of insulin gene expression by glucose and calcium in transfected primary islet cultures. J Biol Chem. 1990 Dec 25;265(36):22063–22066. [PubMed] [Google Scholar]
  12. Goodison S., Kenna S., Ashcroft S. J. Control of insulin gene expression by glucose. Biochem J. 1992 Jul 15;285(Pt 2):563–568. doi: 10.1042/bj2850563. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Herold K. C., Nagamatsu S., Buse J. B., Kulsakdinun P., Steiner D. F. Inhibition of glucose-stimulated insulin release from beta TC3 cells and rodent islets by an analog of FK506. Transplantation. 1993 Jan;55(1):186–192. doi: 10.1097/00007890-199301000-00035. [DOI] [PubMed] [Google Scholar]
  14. Hirano Y., Fujihira S., Ohara K., Katsuki S., Noguchi H. Morphological and functional changes of islets of Langerhans in FK506-treated rats. Transplantation. 1992 Apr;53(4):889–894. doi: 10.1097/00007890-199204000-00033. [DOI] [PubMed] [Google Scholar]
  15. Jacoby D. B., Zilz N. D., Towle H. C. Sequences within the 5'-flanking region of the S14 gene confer responsiveness to glucose in primary hepatocytes. J Biol Chem. 1989 Oct 25;264(30):17623–17626. [PubMed] [Google Scholar]
  16. Krentz A. J., Dousset B., Mayer D., McMaster P., Buckels J., Cramb R., Smith J. M., Nattrass M. Metabolic effects of cyclosporin A and FK 506 in liver transplant recipients. Diabetes. 1993 Dec;42(12):1753–1759. doi: 10.2337/diab.42.12.1753. [DOI] [PubMed] [Google Scholar]
  17. Liu J. FK506 and cyclosporin, molecular probes for studying intracellular signal transduction. Immunol Today. 1993 Jun;14(6):290–295. doi: 10.1016/0167-5699(93)90048-P. [DOI] [PubMed] [Google Scholar]
  18. Melloul D., Cerasi E. Transcription of the insulin gene: towards defining the glucose-sensitive cis-element and trans-acting factors. Diabetologia. 1994 Sep;37 (Suppl 2):S3–10. doi: 10.1007/BF00400820. [DOI] [PubMed] [Google Scholar]
  19. Morris S. M., Jr, Kepka-Lenhart D., McGill R. L., Curthoys N. P., Adler S. Specific disruption of renal function and gene transcription by cyclosporin A. J Biol Chem. 1992 Jul 5;267(19):13768–13771. [PubMed] [Google Scholar]
  20. Müller M. K., Wojcik M., Coone H., Philipp T., Singer M. V. Inhibition of insulin release by FK 506 and its prevention by rioprostil, a stable prostaglandin E1 analogue. Transplant Proc. 1991 Dec;23(6):2812–2813. [PubMed] [Google Scholar]
  21. Nielsen D. A., Welsh M., Casadaban M. J., Steiner D. F. Control of insulin gene expression in pancreatic beta-cells and in an insulin-producing cell line, RIN-5F cells. I. Effects of glucose and cyclic AMP on the transcription of insulin mRNA. J Biol Chem. 1985 Nov 5;260(25):13585–13589. [PubMed] [Google Scholar]
  22. O'Keefe S. J., Tamura J., Kincaid R. L., Tocci M. J., O'Neill E. A. FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin. Nature. 1992 Jun 25;357(6380):692–694. doi: 10.1038/357692a0. [DOI] [PubMed] [Google Scholar]
  23. Odocha O., McCauley J., Scantlebury V., Shapiro R., Carroll P., Jordan M., Vivas C., Fung J. J., Starzl T. E. Posttransplant diabetes mellitus in African Americans after renal transplantation under FK 506 immunosuppression. Transplant Proc. 1993 Aug;25(4):2433–2434. [PMC free article] [PubMed] [Google Scholar]
  24. Olson L. K., Redmon J. B., Towle H. C., Robertson R. P. Chronic exposure of HIT cells to high glucose concentrations paradoxically decreases insulin gene transcription and alters binding of insulin gene regulatory protein. J Clin Invest. 1993 Jul;92(1):514–519. doi: 10.1172/JCI116596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Olson L. K., Sharma A., Peshavaria M., Wright C. V., Towle H. C., Rodertson R. P., Stein R. Reduction of insulin gene transcription in HIT-T15 beta cells chronically exposed to a supraphysiologic glucose concentration is associated with loss of STF-1 transcription factor expression. Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9127–9131. doi: 10.1073/pnas.92.20.9127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Permutt M. A., Kipnis D. M. Insulin biosynthesis. I. On the mechanism of glucose stimulation. J Biol Chem. 1972 Feb 25;247(4):1194–1199. [PubMed] [Google Scholar]
  27. Philippe J. Somatostatin inhibits insulin-gene expression through a posttranscriptional mechanism in a hamster islet cell line. Diabetes. 1993 Feb;42(2):244–249. doi: 10.2337/diab.42.2.244. [DOI] [PubMed] [Google Scholar]
  28. Philippe J. Structure and pancreatic expression of the insulin and glucagon genes. Endocr Rev. 1991 Aug;12(3):252–271. doi: 10.1210/edrv-12-3-252. [DOI] [PubMed] [Google Scholar]
  29. Redmon J. B., Towle H. C., Robertson R. P. Regulation of human insulin gene transcription by glucose, epinephrine, and somatostatin. Diabetes. 1994 Apr;43(4):546–551. doi: 10.2337/diab.43.4.546. [DOI] [PubMed] [Google Scholar]
  30. Santerre R. F., Cook R. A., Crisel R. M., Sharp J. D., Schmidt R. J., Williams D. C., Wilson C. P. Insulin synthesis in a clonal cell line of simian virus 40-transformed hamster pancreatic beta cells. Proc Natl Acad Sci U S A. 1981 Jul;78(7):4339–4343. doi: 10.1073/pnas.78.7.4339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Sawada S., Suzuki G., Kawase Y., Takaku F. Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation. J Immunol. 1987 Sep 15;139(6):1797–1803. [PubMed] [Google Scholar]
  32. Scantlebury V., Shapiro R., Fung J., Tzakis A., McCauley J., Jordan M., Jensen C., Hakala T., Simmons R., Starzl T. E. New onset of diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients. Transplant Proc. 1991 Dec;23(6):3169–3170. [PMC free article] [PubMed] [Google Scholar]
  33. Schreiber E., Matthias P., Müller M. M., Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 1989 Aug 11;17(15):6419–6419. doi: 10.1093/nar/17.15.6419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Schreiber S. L. Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science. 1991 Jan 18;251(4991):283–287. doi: 10.1126/science.1702904. [DOI] [PubMed] [Google Scholar]
  35. Schwaninger M., Blume R., Oetjen E., Lux G., Knepel W. Inhibition of cAMP-responsive element-mediated gene transcription by cyclosporin A and FK506 after membrane depolarization. J Biol Chem. 1993 Nov 5;268(31):23111–23115. [PubMed] [Google Scholar]
  36. Seaquist E. R., Neal A. R., Shoger K. D., Walseth T. F., Robertson R. P. G-proteins and hormonal inhibition of insulin secretion from HIT-T15 cells and isolated rat islets. Diabetes. 1992 Nov;41(11):1390–1399. doi: 10.2337/diab.41.11.1390. [DOI] [PubMed] [Google Scholar]
  37. Shapiro R., Jordan M., Fung J., McCauley J., Johnston J., Iwaki Y., Tzakis A., Hakala T., Todo S., Starzl T. E. Kidney transplantation under FK 506 immunosuppression. Transplant Proc. 1991 Feb;23(1 Pt 2):920–923. [PMC free article] [PubMed] [Google Scholar]
  38. Sharma A., Olson L. K., Robertson R. P., Stein R. The reduction of insulin gene transcription in HIT-T15 beta cells chronically exposed to high glucose concentration is associated with the loss of RIPE3b1 and STF-1 transcription factor expression. Mol Endocrinol. 1995 Sep;9(9):1127–1134. doi: 10.1210/mend.9.9.7491105. [DOI] [PubMed] [Google Scholar]
  39. Strasser S., Alejandro R., Shapiro E. T., Ricordi C., Todo S., Mintz D. H. Effect of FK506 on insulin secretion in normal dogs. Metabolism. 1992 Jan;41(1):64–67. doi: 10.1016/0026-0495(92)90192-d. [DOI] [PubMed] [Google Scholar]
  40. Tamura K., Fujimura T., Tsutsumi T., Nakamura K., Ogawa T., Atumaru C., Hirano Y., Ohara K., Ohtsuka K., Shimomura K. Transcriptional inhibition of insulin by FK506 and possible involvement of FK506 binding protein-12 in pancreatic beta-cell. Transplantation. 1995 Jun 15;59(11):1606–1613. [PubMed] [Google Scholar]
  41. Tze W. J., Tai J., Murase N., Tzakis A., Starzl T. E. Effect of FK 506 on glucose metabolism and insulin secretion in normal rats. Transplant Proc. 1991 Dec;23(6):3158–3160. [PMC free article] [PubMed] [Google Scholar]
  42. Welsh M., Nielsen D. A., MacKrell A. J., Steiner D. F. Control of insulin gene expression in pancreatic beta-cells and in an insulin-producing cell line, RIN-5F cells. II. Regulation of insulin mRNA stability. J Biol Chem. 1985 Nov 5;260(25):13590–13594. [PubMed] [Google Scholar]
  43. Welsh M., Weber T., Wrange O., Nielsen D. A., Matthieu M., Steiner D. F. Regulation of insulin gene expression by dexamethasone, Ca2+ and a phorbol ester. Biomed Biochim Acta. 1988;47(4-5):299–303. [PubMed] [Google Scholar]
  44. Zhang H. J., Petersen B., Robertson R. P. Variable regulation by insulin of insulin gene expression in HIT-T15 cells. Diabetologia. 1994 Jun;37(6):559–566. doi: 10.1007/BF00403373. [DOI] [PubMed] [Google Scholar]
  45. Zhang H. J., Redmon J. B., Andresen J. M., Robertson R. P. Somatostatin and epinephrine decrease insulin messenger ribonucleic acid in HIT cells through a pertussis toxin-sensitive mechanism. Endocrinology. 1991 Nov;129(5):2409–2414. doi: 10.1210/endo-129-5-2409. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES